Skip to main content
$4.76 -0.16 (-3.25%) At close · Jul 28
Market Cap
$26.78M
Shares
5.63M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.76 Open$4.89 Day$4.65–4.89 52W$4.00–6.40 Avg vol 30d105K Short int72K · 1.3% float · 1.0d Short vol62% DataMay 2026–Jul 2026

Up next

FQ4-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.2 · elevated Equity put/call 0.71
Technical
price trend
Neutral
50 / 200-day cross No cross
RSI (14) 49
neutral
MACD trend Positive
52-week position 32%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.28% of float · ▲ +9.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 42
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 114%
annualized · 1-yr
Max drawdown −34%
past year
ATR 9.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 3 · 1
50 / 200-day cross
No cross Neutral
RSI (14)
49 Neutral
MACD trend
Positive Bullish
52-week position
32% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.28% of float · ▲ +9.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $4 Now $5 · 32% 52-wk high $6

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OPTH
Optimi Health Corp.
this stock
$26.78M 1.3%
TAK
Takeda Pharmaceutical Co Ltd
$56.03B +12.4% 0.1%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$51.90B 0.0%
GALDY
Galderma Group AG/ADR
$50.49B +4.5% 0.0%
HLN
Haleon plc
$45.23B +1.6% 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
72.2K
Days to cover
1.0d
Change
+6.2K sh
View
Short Volume
Short vol %
62%
As of
Jul 28, 2026
Short Total
View
Fails to Deliver
FTD shares
7.1K
Value
$31.6K
As of
Jun 30, 2026
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 28, 2026
This year
10
View
Exempt Offerings
Offering
$321.2K
Filed
Aug 26, 2024
View

Performance

5D 20D 120D MTD YTD
OPTH +0.2% +7.2% -6.5%
SPY -1.0% 0.0% +7.4% -0.8% +8.6%
vs SPY +1.2% +7.2% -5.7%
Key facts CIK 2027329 CUSIP 68405H308 13F (30d) 1 filings 1 filers Visit website Investor relations